Your browser doesn't support javascript.
loading
How Real-World Data Can Facilitate the Development of Precision Medicine Treatment in Psychiatry.
Koch, Elise; Pardiñas, Antonio F; O'Connell, Kevin S; Selvaggi, Pierluigi; Camacho Collados, José; Babic, Aleksandar; Marshall, Serena E; Van der Eycken, Erik; Angulo, Cecilia; Lu, Yi; Sullivan, Patrick F; Dale, Anders M; Molden, Espen; Posthuma, Danielle; White, Nathan; Schubert, Alexander; Djurovic, Srdjan; Heimer, Hakon; Stefánsson, Hreinn; Stefánsson, Kári; Werge, Thomas; Sønderby, Ida; O'Donovan, Michael C; Walters, James T R; Milani, Lili; Andreassen, Ole A.
Afiliación
  • Koch E; Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: e.m.koch@medisin.uio.no.
  • Pardiñas AF; Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • O'Connell KS; Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Selvaggi P; Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, Bari, Italy.
  • Camacho Collados J; CardiffNLP, School of Computer Science and Informatics, Cardiff University, Cardiff, United Kingdom.
  • Babic A; Det Norske Veritas, Oslo, Norway.
  • Marshall SE; Det Norske Veritas, Oslo, Norway.
  • Van der Eycken E; Global Alliance of Mental Illness Advocacy Networks-Europe, Brussels, Belgium.
  • Angulo C; Global Alliance of Mental Illness Advocacy Networks-Europe, Brussels, Belgium.
  • Lu Y; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden.
  • Sullivan PF; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden; Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill, North Carolina.
  • Dale AM; Multimodal Imaging Laboratory, University of California San Diego, La Jolla, California; Departments of Radiology, Psychiatry, and Neurosciences, University of California, San Diego, La Jolla, California.
  • Molden E; Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
  • Posthuma D; Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • White N; CorTechs Laboratories, Inc., San Diego, California.
  • Schubert A; European College of Neuropsychopharmacology, Utrecht, the Netherlands.
  • Djurovic S; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; The Norwegian Centre for Mental Disorders Research Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Heimer H; Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Nordic Society of Human Genetics and Precision Medicine, Copenhagen, Denmark.
  • Stefánsson H; deCODE Genetics, Reykjavik, Iceland.
  • Stefánsson K; deCODE Genetics, Reykjavik, Iceland.
  • Werge T; Institute of Biological Psychiatry, Mental Health Center Sct. Hans, Mental Health Services Copenhagen, Roskilde, Denmark; Lundbeck Foundation Initiative for Integrative Psychiatric Research, Copenhagen, Denmark; Lundbeck Foundation GeoGenetics Centre, GLOBE Institute, University of Copenhagen, Copen
  • Sønderby I; Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for Neurodevelopmental Dis
  • O'Donovan MC; Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Walters JTR; Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Milani L; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia; Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia.
  • Andreassen OA; Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway; KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo and Oslo University Hospital, Oslo, Norway. E
Biol Psychiatry ; 96(7): 543-551, 2024 Oct 01.
Article en En | MEDLINE | ID: mdl-38185234
ABSTRACT
Precision medicine has the ambition to improve treatment response and clinical outcomes through patient stratification and holds great potential for the treatment of mental disorders. However, several important factors are needed to transform current practice into a precision psychiatry framework. Most important are 1) the generation of accessible large real-world training and test data including genomic data integrated from multiple sources, 2) the development and validation of advanced analytical tools for stratification and prediction, and 3) the development of clinically useful management platforms for patient monitoring that can be integrated into health care systems in real-life settings. This narrative review summarizes strategies for obtaining the key elements-well-powered samples from large biobanks integrated with electronic health records and health registry data using novel artificial intelligence algorithms-to predict outcomes in severe mental disorders and translate these models into clinical management and treatment approaches. Key elements are massive mental health data and novel artificial intelligence algorithms. For the clinical translation of these strategies, we discuss a precision medicine platform for improved management of mental disorders. We use cases to illustrate how precision medicine interventions could be brought into psychiatry to improve the clinical outcomes of mental disorders.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Psiquiatría / Medicina de Precisión / Trastornos Mentales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Biol Psychiatry Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Psiquiatría / Medicina de Precisión / Trastornos Mentales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Biol Psychiatry Año: 2024 Tipo del documento: Article